

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | positive regulation of chemokine secretion (GO:0090197) | 4.60451741 |
| 2 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 4.05930345 |
| 3 | positive regulation of gamma-delta T cell activation (GO:0046645) | 4.05627737 |
| 4 | microglial cell activation (GO:0001774) | 4.05508558 |
| 5 | detection of external biotic stimulus (GO:0098581) | 4.01816167 |
| 6 | positive regulation of myeloid leukocyte mediated immunity (GO:0002888) | 3.95876459 |
| 7 | positive regulation of mast cell activation (GO:0033005) | 3.95816134 |
| 8 | detection of other organism (GO:0098543) | 3.83945631 |
| 9 | positive regulation by symbiont of host defense response (GO:0052509) | 3.70961054 |
| 10 | modulation by symbiont of host defense response (GO:0052031) | 3.70961054 |
| 11 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 3.70961054 |
| 12 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 3.70961054 |
| 13 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 3.70961054 |
| 14 | modulation by symbiont of host immune response (GO:0052553) | 3.70961054 |
| 15 | detection of biotic stimulus (GO:0009595) | 3.62517883 |
| 16 | negative regulation of interleukin-12 production (GO:0032695) | 3.62119154 |
| 17 | regulation of chemokine secretion (GO:0090196) | 3.49139285 |
| 18 | cellular response to thyroid hormone stimulus (GO:0097067) | 3.48982936 |
| 19 | positive regulation of nitric-oxide synthase biosynthetic process (GO:0051770) | 3.43390884 |
| 20 | G-protein coupled purinergic nucleotide receptor signaling pathway (GO:0035589) | 3.40917088 |
| 21 | macrophage activation involved in immune response (GO:0002281) | 3.39334868 |
| 22 | apoptotic cell clearance (GO:0043277) | 3.35465007 |
| 23 | regulation of myeloid leukocyte mediated immunity (GO:0002886) | 3.32156514 |
| 24 | wound healing, spreading of epidermal cells (GO:0035313) | 3.28121383 |
| 25 | detection of bacterium (GO:0016045) | 3.24594233 |
| 26 | regulation of mast cell degranulation (GO:0043304) | 3.20985516 |
| 27 | regulation of mononuclear cell migration (GO:0071675) | 3.16737119 |
| 28 | regulation of mast cell activation (GO:0033003) | 3.16161135 |
| 29 | neutrophil activation involved in immune response (GO:0002283) | 3.10201681 |
| 30 | regulation of mast cell activation involved in immune response (GO:0033006) | 3.09218803 |
| 31 | positive regulation of syncytium formation by plasma membrane fusion (GO:0060143) | 3.03191243 |
| 32 | regulation of gamma-delta T cell activation (GO:0046643) | 2.96510839 |
| 33 | regulation of interferon-beta biosynthetic process (GO:0045357) | 2.95283898 |
| 34 | glycosphingolipid catabolic process (GO:0046479) | 2.94616166 |
| 35 | positive regulation of cellular amide metabolic process (GO:0034250) | 2.94162122 |
| 36 | regulation of leukocyte degranulation (GO:0043300) | 2.92665687 |
| 37 | cellular response to ethanol (GO:0071361) | 2.91867057 |
| 38 | negative regulation of cell killing (GO:0031342) | 2.91116995 |
| 39 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 2.91116995 |
| 40 | regulation of hypersensitivity (GO:0002883) | 2.90914546 |
| 41 | immunoglobulin mediated immune response (GO:0016064) | 2.90446205 |
| 42 | central nervous system myelination (GO:0022010) | 2.81857155 |
| 43 | axon ensheathment in central nervous system (GO:0032291) | 2.81857155 |
| 44 | phagocytosis, engulfment (GO:0006911) | 2.81715403 |
| 45 | cellular extravasation (GO:0045123) | 2.80987542 |
| 46 | virion attachment to host cell (GO:0019062) | 2.80717951 |
| 47 | adhesion of symbiont to host cell (GO:0044650) | 2.80717951 |
| 48 | long-chain fatty acid biosynthetic process (GO:0042759) | 2.80302148 |
| 49 | regulation of macrophage cytokine production (GO:0010935) | 2.79649933 |
| 50 | amino sugar catabolic process (GO:0046348) | 2.79226454 |
| 51 | positive regulation of macrophage cytokine production (GO:0060907) | 2.76593449 |
| 52 | negative regulation of amyloid precursor protein catabolic process (GO:1902992) | 2.75791014 |
| 53 | oligosaccharide catabolic process (GO:0009313) | 2.74095362 |
| 54 | regulation of platelet activation (GO:0010543) | 2.72180435 |
| 55 | keratan sulfate catabolic process (GO:0042340) | 2.70830151 |
| 56 | G-protein coupled purinergic receptor signaling pathway (GO:0035588) | 2.70120549 |
| 57 | regulation of monocyte chemotaxis (GO:0090025) | 2.67141091 |
| 58 | positive regulation of tumor necrosis factor biosynthetic process (GO:0042535) | 2.66515959 |
| 59 | positive regulation of monocyte chemotaxis (GO:0090026) | 2.65947317 |
| 60 | regulation of chemokine-mediated signaling pathway (GO:0070099) | 2.63902945 |
| 61 | positive regulation of bone resorption (GO:0045780) | 2.62965714 |
| 62 | positive regulation of bone remodeling (GO:0046852) | 2.62965714 |
| 63 | macrophage activation (GO:0042116) | 2.61894957 |
| 64 | glycolipid catabolic process (GO:0019377) | 2.61298209 |
| 65 | neutrophil chemotaxis (GO:0030593) | 2.60972997 |
| 66 | adenosine receptor signaling pathway (GO:0001973) | 2.60445356 |
| 67 | cyclooxygenase pathway (GO:0019371) | 2.59855150 |
| 68 | positive regulation of cholesterol efflux (GO:0010875) | 2.59124044 |
| 69 | purinergic nucleotide receptor signaling pathway (GO:0035590) | 2.59020168 |
| 70 | wound healing, spreading of cells (GO:0044319) | 2.58727979 |
| 71 | response to muramyl dipeptide (GO:0032495) | 2.58484517 |
| 72 | positive regulation of toll-like receptor signaling pathway (GO:0034123) | 2.57347554 |
| 73 | respiratory burst (GO:0045730) | 2.56729385 |
| 74 | regulation of tumor necrosis factor biosynthetic process (GO:0042534) | 2.55240112 |
| 75 | neutrophil migration (GO:1990266) | 2.54632346 |
| 76 | leukocyte migration involved in inflammatory response (GO:0002523) | 2.52147965 |
| 77 | regulation of gamma-delta T cell differentiation (GO:0045586) | 2.51539904 |
| 78 | response to peptidoglycan (GO:0032494) | 2.51421359 |
| 79 | regulation of beta-amyloid formation (GO:1902003) | 2.49416617 |
| 80 | regulation of macrophage chemotaxis (GO:0010758) | 2.48013653 |
| 81 | myeloid cell activation involved in immune response (GO:0002275) | 2.47096770 |
| 82 | positive regulation of myeloid leukocyte cytokine production involved in immune response (GO:0061081 | 2.46965563 |
| 83 | glomerular basement membrane development (GO:0032836) | 2.44648725 |
| 84 | positive regulation of B cell differentiation (GO:0045579) | 2.43132993 |
| 85 | negative regulation of erythrocyte differentiation (GO:0045647) | 2.40845252 |
| 86 | positive regulation of interleukin-8 biosynthetic process (GO:0045416) | 2.40776494 |
| 87 | cell adhesion mediated by integrin (GO:0033627) | 2.39768495 |
| 88 | positive regulation of astrocyte differentiation (GO:0048711) | 2.38665132 |
| 89 | regulation of antigen processing and presentation of peptide antigen (GO:0002583) | 2.37470679 |
| 90 | regulation of B cell receptor signaling pathway (GO:0050855) | 2.37348126 |
| 91 | regulation of regulated secretory pathway (GO:1903305) | 2.36568603 |
| 92 | lipoxygenase pathway (GO:0019372) | 2.36278193 |
| 93 | regulation of cholesterol storage (GO:0010885) | 2.35993309 |
| 94 | regulation of syncytium formation by plasma membrane fusion (GO:0060142) | 2.35657169 |
| 95 | interferon-gamma-mediated signaling pathway (GO:0060333) | 2.35194056 |
| 96 | response to immune response of other organism involved in symbiotic interaction (GO:0052564) | 2.35044330 |
| 97 | response to host immune response (GO:0052572) | 2.35044330 |
| 98 | purinergic receptor signaling pathway (GO:0035587) | 2.33085324 |
| 99 | granulocyte chemotaxis (GO:0071621) | 2.32996930 |
| 100 | regulation of T-helper 2 cell differentiation (GO:0045628) | 2.32748080 |
| 101 | cortical actin cytoskeleton organization (GO:0030866) | 2.32396488 |
| 102 | epithelial cell differentiation involved in prostate gland development (GO:0060742) | 2.32054093 |
| 103 | membrane raft organization (GO:0031579) | 2.31894123 |
| 104 | granulocyte activation (GO:0036230) | 2.31015251 |
| 105 | phagocytosis, recognition (GO:0006910) | 2.30981794 |
| 106 | collagen fibril organization (GO:0030199) | 2.30889376 |
| 107 | extracellular matrix assembly (GO:0085029) | 2.30737039 |
| 108 | nerve growth factor signaling pathway (GO:0038180) | 2.30711946 |
| 109 | ceramide catabolic process (GO:0046514) | 2.30422497 |
| 110 | production of molecular mediator involved in inflammatory response (GO:0002532) | 2.30349896 |
| 111 | regulation of platelet aggregation (GO:0090330) | 2.30097883 |
| 112 | positive regulation of antigen processing and presentation (GO:0002579) | 2.30032379 |
| 113 | detection of molecule of bacterial origin (GO:0032490) | 2.29816456 |
| 114 | positive regulation of cholesterol transport (GO:0032376) | 2.29652654 |
| 115 | negative regulation of interleukin-17 production (GO:0032700) | 2.29575180 |
| 116 | response to laminar fluid shear stress (GO:0034616) | 2.27815002 |
| 117 | T-helper 1 type immune response (GO:0042088) | 2.27618858 |
| 118 | response to defenses of other organism involved in symbiotic interaction (GO:0052173) | 2.26816848 |
| 119 | response to host (GO:0075136) | 2.26816848 |
| 120 | response to host defenses (GO:0052200) | 2.26816848 |
| 121 | superoxide anion generation (GO:0042554) | 2.26634347 |
| 122 | positive regulation of interferon-alpha production (GO:0032727) | 2.26147017 |
| 123 | neutrophil activation (GO:0042119) | 2.25821834 |
| 124 | cellular response to interferon-alpha (GO:0035457) | 2.24339796 |
| 125 | response to lipoprotein particle (GO:0055094) | 2.21891253 |
| 126 | cortical cytoskeleton organization (GO:0030865) | 2.21749222 |
| 127 | chondroitin sulfate catabolic process (GO:0030207) | 2.20835552 |
| 128 | positive regulation of mast cell degranulation (GO:0043306) | 2.20780262 |
| 129 | positive regulation of mast cell activation involved in immune response (GO:0033008) | 2.20780262 |
| 130 | negative regulation of granulocyte differentiation (GO:0030853) | 2.18626232 |
| 131 | import into cell (GO:0098657) | 2.16978762 |
| 132 | monocyte chemotaxis (GO:0002548) | 2.15738236 |
| 133 | axon ensheathment (GO:0008366) | 2.15072537 |
| 134 | ensheathment of neurons (GO:0007272) | 2.15072537 |
| 135 | regulation of lymphocyte migration (GO:2000401) | 2.14561489 |
| 136 | regulation of T cell migration (GO:2000404) | 2.14550820 |
| 137 | negative regulation of interleukin-6 production (GO:0032715) | 2.13331947 |
| 138 | myelination (GO:0042552) | 2.12902975 |
| 139 | lipopolysaccharide-mediated signaling pathway (GO:0031663) | 2.12404114 |
| 140 | regulation of antigen processing and presentation (GO:0002577) | 2.12167654 |
| 141 | endodermal cell differentiation (GO:0035987) | 2.11767156 |
| 142 | glomerular visceral epithelial cell development (GO:0072015) | 2.10962867 |
| 143 | platelet-derived growth factor receptor signaling pathway (GO:0048008) | 2.10927496 |
| 144 | positive regulation of chemokine production (GO:0032722) | 2.10924845 |
| 145 | regulation of interferon-alpha production (GO:0032647) | 2.10167849 |
| 146 | positive regulation of granulocyte macrophage colony-stimulating factor production (GO:0032725) | 2.09306933 |
| 147 | germinal center formation (GO:0002467) | 2.09092072 |
| 148 | positive regulation of interleukin-6 production (GO:0032755) | 2.05991691 |
| 149 | positive regulation of leukocyte degranulation (GO:0043302) | 2.05097205 |
| 150 | negative regulation of toll-like receptor 4 signaling pathway (GO:0034144) | 2.05044496 |
| 151 | adhesion of symbiont to host (GO:0044406) | 2.04811252 |
| 152 | positive regulation of T cell chemotaxis (GO:0010820) | 2.04672906 |
| 153 | regulation of T cell chemotaxis (GO:0010819) | 2.04672906 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 4.67345195 |
| 2 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 3.08261599 |
| 3 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 2.98491730 |
| 4 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 2.79633730 |
| 5 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 2.75291912 |
| 6 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 2.52621826 |
| 7 | GATA1_22025678_ChIP-Seq_K562_Human | 2.39659757 |
| 8 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 2.27075077 |
| 9 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 2.14579334 |
| 10 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 1.99845706 |
| 11 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 1.97702522 |
| 12 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 1.95323601 |
| 13 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 1.87607140 |
| 14 | ESR1_22446102_ChIP-Seq_UTERUS_Mouse | 1.75681932 |
| 15 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 1.73892541 |
| 16 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.66133350 |
| 17 | * CJUN_26792858_Chip-Seq_BT549_Human | 1.65382820 |
| 18 | * CEBPD_23245923_ChIP-Seq_MEFs_Mouse | 1.62560970 |
| 19 | PPARD_23176727_ChIP-Seq_KERATINOCYTES_Mouse | 1.53416557 |
| 20 | * SUZ12_18974828_ChIP-Seq_MESCs_Mouse | 1.52905396 |
| 21 | GBX2_23144817_ChIP-Seq_PC3_Human | 1.52138941 |
| 22 | * NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 1.51752479 |
| 23 | * NRF2_20460467_ChIP-Seq_MEFs_Mouse | 1.51752479 |
| 24 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 1.51382952 |
| 25 | SUZ12_16625203_ChIP-ChIP_MESCs_Mouse | 1.50442373 |
| 26 | TP53_16413492_ChIP-PET_HCT116_Human | 1.49606685 |
| 27 | WT1_19549856_ChIP-ChIP_CCG9911_Human | 1.49042066 |
| 28 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 1.46855432 |
| 29 | SUZ12_18555785_ChIP-Seq_MESCs_Mouse | 1.46825368 |
| 30 | VDR_24787735_ChIP-Seq_THP-1_Human | 1.45584873 |
| 31 | TP53_18474530_ChIP-ChIP_U2OS_Human | 1.45510519 |
| 32 | * CEBPD_21427703_ChIP-Seq_3T3-L1_Mouse | 1.45345270 |
| 33 | * ZNF217_24962896_ChIP-Seq_MCF-7_Human | 1.44830365 |
| 34 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 1.44155353 |
| 35 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 1.44029785 |
| 36 | SUZ12_18692474_ChIP-Seq_MEFs_Mouse | 1.43226198 |
| 37 | EED_16625203_ChIP-ChIP_MESCs_Mouse | 1.43031352 |
| 38 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 1.42939356 |
| 39 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.39037002 |
| 40 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 1.37225160 |
| 41 | SUZ12_18692474_ChIP-Seq_MESCs_Mouse | 1.33252870 |
| 42 | EZH2_18974828_ChIP-Seq_MESCs_Mouse | 1.31550322 |
| 43 | RNF2_18974828_ChIP-Seq_MESCs_Mouse | 1.31550322 |
| 44 | * PPARG_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.30374089 |
| 45 | RUNX_20019798_ChIP-Seq_JUKART_Human | 1.29859433 |
| 46 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 1.29549514 |
| 47 | * GATA1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.25726675 |
| 48 | SMAD4_19686287_ChIP-ChIP_HaCaT_Human | 1.24840809 |
| 49 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 1.24699480 |
| 50 | SOX9_24532713_ChIP-Seq_HFSC_Mouse | 1.24570012 |
| 51 | MTF2_20144788_ChIP-Seq_MESCs_Mouse | 1.23996804 |
| 52 | EP300_21415370_ChIP-Seq_HL-1_Mouse | 1.22002093 |
| 53 | * PAX3-FKHR_20663909_ChIP-Seq_RHABDOMYOSARCOMA_Human | 1.21494408 |
| 54 | JARID2_20064375_ChIP-Seq_MESCs_Mouse | 1.19468158 |
| 55 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 1.19236662 |
| 56 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.18886697 |
| 57 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.16907150 |
| 58 | FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 1.16223984 |
| 59 | VDR_24763502_ChIP-Seq_THP-1_Human | 1.16049039 |
| 60 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 1.15866283 |
| 61 | SOX2_20726797_ChIP-Seq_SW620_Human | 1.15530942 |
| 62 | DROSHA_22980978_ChIP-Seq_HELA_Human | 1.15281922 |
| 63 | * SMARCA4_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.14689992 |
| 64 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 1.14359823 |
| 65 | PPARG_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.13810867 |
| 66 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 1.13214743 |
| 67 | NFE2L2_22581777_ChIP-Seq_LYMPHOBLASTOID_Human | 1.12838116 |
| 68 | PHC1_16625203_ChIP-ChIP_MESCs_Mouse | 1.12456907 |
| 69 | PU_27001747_Chip-Seq_BMDM_Mouse | 1.10576915 |
| 70 | AR_21572438_ChIP-Seq_LNCaP_Human | 1.10376436 |
| 71 | CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 1.09408159 |
| 72 | * SUZ12_20075857_ChIP-Seq_MESCs_Mouse | 1.09103030 |
| 73 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 1.08531932 |
| 74 | * MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 1.07890952 |
| 75 | RNF2_16625203_ChIP-ChIP_MESCs_Mouse | 1.07612916 |
| 76 | EP300_20729851_ChIP-Seq_FORBRAIN_MIDBRAIN_LIMB_HEART_Mouse | 1.07249323 |
| 77 | GATA1_19941826_ChIP-Seq_K562_Human | 1.07050161 |
| 78 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 1.06019628 |
| 79 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.05996106 |
| 80 | PPAR_26484153_Chip-Seq_NCI-H1993_Human | 1.05259984 |
| 81 | SCL_19346495_ChIP-Seq_HPC-7_Human | 1.03896623 |
| 82 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 1.03632432 |
| 83 | PIAS1_25552417_ChIP-Seq_VCAP_Human | 1.03060479 |
| 84 | JARID2_20075857_ChIP-Seq_MESCs_Mouse | 1.02903104 |
| 85 | SPI1_23127762_ChIP-Seq_K562_Human | 1.02323363 |
| 86 | SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.02178148 |
| 87 | SPI1_23547873_ChIP-Seq_NB4_Human | 1.02141514 |
| 88 | EZH2_27304074_Chip-Seq_ESCs_Mouse | 1.01824693 |
| 89 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 1.01402821 |
| 90 | * P63_26484246_Chip-Seq_KERATINOCYTES_Human | 1.00674988 |
| 91 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 1.00515314 |
| 92 | RNF2_27304074_Chip-Seq_ESCs_Mouse | 1.00316614 |
| 93 | BCL11B_21912641_ChIP-Seq_STHDH_STRIUM_Mouse | 1.00298375 |
| 94 | GATA2_19941826_ChIP-Seq_K562_Human | 0.99217492 |
| 95 | * TP63_23658742_ChIP-Seq_EP156T_Human | 0.98949943 |
| 96 | RXR_22108803_ChIP-Seq_LS180_Human | 0.98211287 |
| 97 | AHR_22903824_ChIP-Seq_MCF-7_Human | 0.96327499 |
| 98 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 0.95382568 |
| 99 | ARNT_22903824_ChIP-Seq_MCF-7_Human | 0.94763332 |
| 100 | * WT1_25993318_ChIP-Seq_PODOCYTE_Human | 0.94565427 |
| 101 | * WT1_20215353_ChIP-ChIP_NEPHRON_PROGENITOR_Mouse | 0.94333029 |
| 102 | PPARG_20176806_ChIP-Seq_3T3-L1_Mouse | 0.93644583 |
| 103 | JUN_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 0.93450476 |
| 104 | CTNNB1_24651522_ChIP-Seq_LGR5+_INTESTINAL_STEM_Human | 0.91119997 |
| 105 | POU5F1_26923725_Chip-Seq_MESODERM_Mouse | 0.89644860 |
| 106 | TEAD4_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 0.89644860 |
| 107 | AR_22383394_ChIP-Seq_PROSTATE_CANCER_Human | 0.89289966 |
| 108 | * FOXA1_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 0.89005334 |
| 109 | * RUNX2_24764292_ChIP-Seq_MC3T3_Mouse | 0.88966016 |
| 110 | * OLIG2_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 0.88775065 |
| 111 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 0.88600156 |
| 112 | SUZ12_27294783_Chip-Seq_ESCs_Mouse | 0.88328824 |
| 113 | SMARCD1_25818293_ChIP-Seq_ESCs_Mouse | 0.88232099 |
| 114 | * FOXO3_23340844_ChIP-Seq_DLD1_Human | 0.88223722 |
| 115 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 0.87674190 |
| 116 | JUND_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 0.86401024 |
| 117 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 0.86261020 |
| 118 | * ZFP57_27257070_Chip-Seq_ESCs_Mouse | 0.85728066 |
| 119 | SMAD3_21741376_ChIP-Seq_HESCs_Human | 0.85639386 |
| 120 | * SMAD4_21799915_ChIP-Seq_A2780_Human | 0.84944035 |
| 121 | SMAD3_22036565_ChIP-Seq_ESCs_Mouse | 0.84879361 |
| 122 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 0.83933735 |
| 123 | GATA1_19941827_ChIP-Seq_MEL86_Mouse | 0.82165416 |
| 124 | TRIM28_17542650_ChIP-ChIP_NTERA2_Human | 0.81740693 |
| 125 | SUZ12_27294783_Chip-Seq_NPCs_Mouse | 0.80225866 |
| 126 | * EZH2_27294783_Chip-Seq_ESCs_Mouse | 0.80138462 |
| 127 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 0.80122973 |
| 128 | SALL4_18804426_ChIP-ChIP_XEN_Mouse | 0.79265862 |
| 129 | * TCFCP2L1_18555785_Chip-Seq_ESCs_Mouse | 0.78031736 |
| 130 | TAF15_26573619_Chip-Seq_HEK293_Human | 0.77673461 |
| 131 | POU3F2_20337985_ChIP-ChIP_501MEL_Human | 0.77096808 |
| 132 | SMRT_27268052_Chip-Seq_Bcells_Human | 0.76831803 |
| 133 | * RUNX1_22412390_ChIP-Seq_EML_Mouse | 0.76700650 |
| 134 | EZH2_27294783_Chip-Seq_NPCs_Mouse | 0.76665997 |
| 135 | CDX2_21402776_ChIP-Seq_INTESTINAL-VILLUS_Mouse | 0.76655162 |
| 136 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 0.76086270 |
| 137 | * ERA_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 0.75133698 |
| 138 | GATA3_27048872_Chip-Seq_THYMUS_Human | 0.74910928 |
| 139 | NR3C1_23031785_ChIP-Seq_PC12_Mouse | 0.74883912 |
| 140 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 0.74721186 |
| 141 | RUNX1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 0.74490277 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0008438_abnormal_cutaneous_collagen | 5.20352181 |
| 2 | MP0005275_abnormal_skin_tensile | 3.71351207 |
| 3 | MP0006082_CNS_inflammation | 3.16001424 |
| 4 | MP0005058_abnormal_lysosome_morphology | 2.87330405 |
| 5 | MP0003303_peritoneal_inflammation | 2.56217074 |
| 6 | MP0001958_emphysema | 2.52631858 |
| 7 | MP0003279_aneurysm | 2.48152283 |
| 8 | MP0003690_abnormal_glial_cell | 2.40774215 |
| 9 | MP0003724_increased_susceptibility_to | 2.38283408 |
| 10 | MP0005503_abnormal_tendon_morphology | 2.32862055 |
| 11 | MP0000920_abnormal_myelination | 2.21995018 |
| 12 | MP0003191_abnormal_cellular_cholesterol | 2.21985909 |
| 13 | MP0002148_abnormal_hypersensitivity_rea | 2.20567525 |
| 14 | MP0002419_abnormal_innate_immunity | 2.06460391 |
| 15 | MP0001851_eye_inflammation | 2.01706857 |
| 16 | MP0003075_altered_response_to | 1.98587222 |
| 17 | MP0001835_abnormal_antigen_presentation | 1.93426820 |
| 18 | MP0001533_abnormal_skeleton_physiology | 1.91875898 |
| 19 | MP0004272_abnormal_basement_membrane | 1.82163743 |
| 20 | MP0005623_abnormal_meninges_morphology | 1.79543683 |
| 21 | MP0003436_decreased_susceptibility_to | 1.78244255 |
| 22 | MP0002998_abnormal_bone_remodeling | 1.74845069 |
| 23 | MP0003566_abnormal_cell_adhesion | 1.72930442 |
| 24 | MP0005000_abnormal_immune_tolerance | 1.69613772 |
| 25 | MP0005397_hematopoietic_system_phenotyp | 1.68250817 |
| 26 | MP0001545_abnormal_hematopoietic_system | 1.68250817 |
| 27 | MP0003941_abnormal_skin_development | 1.67647817 |
| 28 | MP0003045_fibrosis | 1.64997001 |
| 29 | MP0005671_abnormal_response_to | 1.58997559 |
| 30 | MP0003705_abnormal_hypodermis_morpholog | 1.55334142 |
| 31 | MP0003172_abnormal_lysosome_physiology | 1.53093328 |
| 32 | MP0005171_absent_coat_pigmentation | 1.52097659 |
| 33 | MP0002295_abnormal_pulmonary_circulatio | 1.51819779 |
| 34 | MP0003183_abnormal_peptide_metabolism | 1.51266325 |
| 35 | MP0005464_abnormal_platelet_physiology | 1.50672267 |
| 36 | MP0009384_cardiac_valve_regurgitation | 1.50368969 |
| 37 | MP0000343_altered_response_to | 1.49566451 |
| 38 | MP0005390_skeleton_phenotype | 1.47470168 |
| 39 | MP0005025_abnormal_response_to | 1.47414498 |
| 40 | MP0009840_abnormal_foam_cell | 1.44633350 |
| 41 | MP0005508_abnormal_skeleton_morphology | 1.42478137 |
| 42 | MP0005387_immune_system_phenotype | 1.41518949 |
| 43 | MP0001790_abnormal_immune_system | 1.41518949 |
| 44 | MP0009785_altered_susceptibility_to | 1.40640908 |
| 45 | MP0003329_amyloid_beta_deposits | 1.40428898 |
| 46 | MP0002060_abnormal_skin_morphology | 1.38082251 |
| 47 | MP0002452_abnormal_antigen_presenting | 1.36579153 |
| 48 | MP0008004_abnormal_stomach_pH | 1.35475080 |
| 49 | MP0000767_abnormal_smooth_muscle | 1.33769979 |
| 50 | MP0004947_skin_inflammation | 1.33514304 |
| 51 | MP0006054_spinal_hemorrhage | 1.33491794 |
| 52 | MP0003300_gastrointestinal_ulcer | 1.32838281 |
| 53 | MP0003136_yellow_coat_color | 1.30011263 |
| 54 | MP0005166_decreased_susceptibility_to | 1.27511383 |
| 55 | MP0002933_joint_inflammation | 1.26640016 |
| 56 | MP0001299_abnormal_eye_distance/ | 1.24980955 |
| 57 | MP0001542_abnormal_bone_strength | 1.24851632 |
| 58 | MP0000685_abnormal_immune_system | 1.23307085 |
| 59 | MP0000465_gastrointestinal_hemorrhage | 1.20951583 |
| 60 | MP0005377_hearing/vestibular/ear_phenot | 1.18399381 |
| 61 | MP0003878_abnormal_ear_physiology | 1.18399381 |
| 62 | MP0000569_abnormal_digit_pigmentation | 1.16706609 |
| 63 | MP0003448_altered_tumor_morphology | 1.16205396 |
| 64 | MP0003828_pulmonary_edema | 1.15891086 |
| 65 | MP0002723_abnormal_immune_serum | 1.14739813 |
| 66 | MP0003195_calcinosis | 1.12430178 |
| 67 | MP0008260_abnormal_autophagy | 1.10168731 |
| 68 | MP0003453_abnormal_keratinocyte_physiol | 1.09987342 |
| 69 | MP0003091_abnormal_cell_migration | 1.09703903 |
| 70 | MP0005164_abnormal_response_to | 1.08343366 |
| 71 | MP0004185_abnormal_adipocyte_glucose | 1.06139647 |
| 72 | MP0005595_abnormal_vascular_smooth | 1.04614947 |
| 73 | MP0002796_impaired_skin_barrier | 1.04364560 |
| 74 | MP0008469_abnormal_protein_level | 1.02003997 |
| 75 | MP0004130_abnormal_muscle_cell | 1.01691909 |
| 76 | MP0005257_abnormal_intraocular_pressure | 0.99361389 |
| 77 | MP0002090_abnormal_vision | 0.99068339 |
| 78 | MP0001819_abnormal_immune_cell | 0.97756619 |
| 79 | MP0003634_abnormal_glial_cell | 0.96162248 |
| 80 | MP0005023_abnormal_wound_healing | 0.95976983 |
| 81 | MP0010155_abnormal_intestine_physiology | 0.94779321 |
| 82 | MP0005451_abnormal_body_composition | 0.94653873 |
| 83 | MP0002420_abnormal_adaptive_immunity | 0.94259882 |
| 84 | MP0004883_abnormal_blood_vessel | 0.93873976 |
| 85 | MP0002896_abnormal_bone_mineralization | 0.93409873 |
| 86 | MP0004510_myositis | 0.92046643 |
| 87 | MP0002168_other_aberrant_phenotype | 0.91721983 |
| 88 | MP0003632_abnormal_nervous_system | 0.91287361 |
| 89 | MP0002133_abnormal_respiratory_system | 0.90695577 |
| 90 | MP0005388_respiratory_system_phenotype | 0.90695577 |
| 91 | MP0001800_abnormal_humoral_immune | 0.90111273 |
| 92 | MP0005310_abnormal_salivary_gland | 0.89995332 |
| 93 | MP0001879_abnormal_lymphatic_vessel | 0.89729822 |
| 94 | MP0001853_heart_inflammation | 0.88835720 |
| 95 | MP0000733_abnormal_muscle_development | 0.87866035 |
| 96 | MP0003011_delayed_dark_adaptation | 0.87722215 |
| 97 | MP0005248_abnormal_Harderian_gland | 0.87571767 |
| 98 | MP0004484_altered_response_of | 0.87543026 |
| 99 | MP0002006_tumorigenesis | 0.86686601 |
| 100 | MP0000716_abnormal_immune_system | 0.86114231 |
| 101 | MP0010368_abnormal_lymphatic_system | 0.85191535 |
| 102 | MP0005409_darkened_coat_color | 0.85051294 |
| 103 | MP0002405_respiratory_system_inflammati | 0.84447849 |
| 104 | MP0005174_abnormal_tail_pigmentation | 0.83861006 |
| 105 | MP0010386_abnormal_urinary_bladder | 0.83772318 |
| 106 | MP0003950_abnormal_plasma_membrane | 0.83719092 |
| 107 | MP0001845_abnormal_inflammatory_respons | 0.82647960 |
| 108 | MP0010678_abnormal_skin_adnexa | 0.81463266 |
| 109 | MP0003795_abnormal_bone_structure | 0.79859512 |
| 110 | MP0005165_increased_susceptibility_to | 0.79821271 |
| 111 | MP0002115_abnormal_skeleton_extremities | 0.79432928 |
| 112 | MP0004134_abnormal_chest_morphology | 0.79054184 |
| 113 | MP0000383_abnormal_hair_follicle | 0.79047569 |
| 114 | MP0009250_abnormal_appendicular_skeleto | 0.78610154 |
| 115 | MP0000604_amyloidosis | 0.78262748 |
| 116 | MP0000249_abnormal_blood_vessel | 0.77905924 |
| 117 | MP0003385_abnormal_body_wall | 0.77835224 |
| 118 | MP0005167_abnormal_blood-brain_barrier | 0.76848225 |
| 119 | MP0010771_integument_phenotype | 0.75318881 |
| 120 | MP0009763_increased_sensitivity_to | 0.74670465 |
| 121 | MP0000858_altered_metastatic_potential | 0.71617106 |
| 122 | MP0005197_abnormal_uvea_morphology | 0.70903795 |
| 123 | MP0002282_abnormal_trachea_morphology | 0.70058039 |
| 124 | MP0003656_abnormal_erythrocyte_physiolo | 0.69416394 |
| 125 | MP0001216_abnormal_epidermal_layer | 0.68773542 |
| 126 | MP0009764_decreased_sensitivity_to | 0.68553829 |
| 127 | MP0000230_abnormal_systemic_arterial | 0.68290742 |
| 128 | MP0009278_abnormal_bone_marrow | 0.68230563 |
| 129 | MP0000689_abnormal_spleen_morphology | 0.66165103 |
| 130 | MP0005647_abnormal_sex_gland | 0.63760584 |
| 131 | MP0000015_abnormal_ear_pigmentation | 0.62896795 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Systemic lupus erythematosus (HP:0002725) | 5.88017888 |
| 2 | Glomerulonephritis (HP:0000099) | 4.67373836 |
| 3 | Eczematoid dermatitis (HP:0000976) | 4.52963450 |
| 4 | Arterial tortuosity (HP:0005116) | 4.48861237 |
| 5 | Vascular tortuosity (HP:0004948) | 4.37548253 |
| 6 | Recurrent abscess formation (HP:0002722) | 4.13036915 |
| 7 | Premature rupture of membranes (HP:0001788) | 4.04420005 |
| 8 | Aortic dissection (HP:0002647) | 3.92084927 |
| 9 | Cerebral aneurysm (HP:0004944) | 3.80064353 |
| 10 | Recurrent bacterial skin infections (HP:0005406) | 3.76085230 |
| 11 | Increased cerebral lipofuscin (HP:0011813) | 3.57479176 |
| 12 | Protrusio acetabuli (HP:0003179) | 3.56340856 |
| 13 | Increased neuronal autofluorescent lipopigment (HP:0002074) | 3.50663551 |
| 14 | Abnormality of glycolipid metabolism (HP:0010969) | 3.50546686 |
| 15 | Abnormality of liposaccharide metabolism (HP:0010968) | 3.50546686 |
| 16 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 3.50546686 |
| 17 | Aortic aneurysm (HP:0004942) | 3.47644304 |
| 18 | Shallow orbits (HP:0000586) | 3.34426036 |
| 19 | Dysostosis multiplex (HP:0000943) | 3.33665618 |
| 20 | Recurrent gram-negative bacterial infections (HP:0005420) | 3.32526481 |
| 21 | Vacuolated lymphocytes (HP:0001922) | 3.24866308 |
| 22 | Axonal loss (HP:0003447) | 3.22097238 |
| 23 | Mutism (HP:0002300) | 3.14811073 |
| 24 | Prolonged bleeding time (HP:0003010) | 3.12968571 |
| 25 | Broad metatarsal (HP:0001783) | 3.08264758 |
| 26 | Orchitis (HP:0100796) | 3.05410807 |
| 27 | Myositis (HP:0100614) | 2.95580691 |
| 28 | Optic neuritis (HP:0100653) | 2.91479538 |
| 29 | Retrobulbar optic neuritis (HP:0100654) | 2.91479538 |
| 30 | Abnormality of macrophages (HP:0004311) | 2.89699627 |
| 31 | Neurofibrillary tangles (HP:0002185) | 2.88982071 |
| 32 | Hematochezia (HP:0002573) | 2.88043110 |
| 33 | Intracellular accumulation of autofluorescent lipopigment storage material (HP:0003204) | 2.87653651 |
| 34 | Purpura (HP:0000979) | 2.85155985 |
| 35 | Disinhibition (HP:0000734) | 2.84886628 |
| 36 | Spondylolisthesis (HP:0003302) | 2.84164921 |
| 37 | Myocardial infarction (HP:0001658) | 2.83866743 |
| 38 | Soft skin (HP:0000977) | 2.82648367 |
| 39 | Nephritis (HP:0000123) | 2.78967426 |
| 40 | Gingival bleeding (HP:0000225) | 2.78663072 |
| 41 | Peritonitis (HP:0002586) | 2.73117151 |
| 42 | Amyloidosis (HP:0011034) | 2.70093502 |
| 43 | Epistaxis (HP:0000421) | 2.61386741 |
| 44 | Vertebral compression fractures (HP:0002953) | 2.59217556 |
| 45 | Abnormality of the vasculature of the conjunctiva (HP:0008054) | 2.57860632 |
| 46 | Chronic mucocutaneous candidiasis (HP:0002728) | 2.52532808 |
| 47 | Recurrent cutaneous fungal infections (HP:0011370) | 2.52532808 |
| 48 | Atrophic scars (HP:0001075) | 2.52161738 |
| 49 | Parakeratosis (HP:0001036) | 2.51515681 |
| 50 | Hypoplasia of the iris (HP:0007676) | 2.51148576 |
| 51 | Recurrent fungal infections (HP:0002841) | 2.50406362 |
| 52 | Disproportionate tall stature (HP:0001519) | 2.48287621 |
| 53 | Mitral valve prolapse (HP:0001634) | 2.40936870 |
| 54 | Osteolytic defects of the phalanges of the hand (HP:0009771) | 2.40700704 |
| 55 | Osteolytic defects of the hand bones (HP:0009699) | 2.40700704 |
| 56 | Absent frontal sinuses (HP:0002688) | 2.40349504 |
| 57 | Keratoconjunctivitis sicca (HP:0001097) | 2.32645208 |
| 58 | Recurrent skin infections (HP:0001581) | 2.30642660 |
| 59 | Gingivitis (HP:0000230) | 2.27412771 |
| 60 | Autoimmune thrombocytopenia (HP:0001973) | 2.26749470 |
| 61 | Complement deficiency (HP:0004431) | 2.26279874 |
| 62 | Hemoptysis (HP:0002105) | 2.26069465 |
| 63 | Mucopolysacchariduria (HP:0008155) | 2.20686679 |
| 64 | Urinary glycosaminoglycan excretion (HP:0003541) | 2.20686679 |
| 65 | Abnormality of complement system (HP:0005339) | 2.20440228 |
| 66 | Segmental peripheral demyelination/remyelination (HP:0003481) | 2.20344998 |
| 67 | Thick nail (HP:0001805) | 2.19803713 |
| 68 | Abnormality of the lumbar spine (HP:0100712) | 2.17169918 |
| 69 | Dilatation of the ascending aorta (HP:0005111) | 2.15836875 |
| 70 | Abnormality of secondary sexual hair (HP:0009888) | 2.14226342 |
| 71 | Abnormality of the axillary hair (HP:0100134) | 2.14226342 |
| 72 | Petechiae (HP:0000967) | 2.12292344 |
| 73 | Mediastinal lymphadenopathy (HP:0100721) | 2.11419788 |
| 74 | Abnormality of the periventricular white matter (HP:0002518) | 2.10755246 |
| 75 | Keratoconjunctivitis (HP:0001096) | 2.07954593 |
| 76 | Pulmonary infiltrates (HP:0002113) | 2.07314790 |
| 77 | Abnormality of mucopolysaccharide metabolism (HP:0011020) | 2.06839363 |
| 78 | Abnormality of polysaccharide metabolism (HP:0011012) | 2.06839363 |
| 79 | Abnormality of glycosaminoglycan metabolism (HP:0004371) | 2.06839363 |
| 80 | Striae distensae (HP:0001065) | 2.04744793 |
| 81 | Increased IgE level (HP:0003212) | 2.03960434 |
| 82 | Pulmonary artery stenosis (HP:0004415) | 2.01451365 |
| 83 | Gastrointestinal infarctions (HP:0005244) | 1.99258829 |
| 84 | Asymmetric septal hypertrophy (HP:0001670) | 1.97807813 |
| 85 | Increased CSF protein (HP:0002922) | 1.97459525 |
| 86 | Congenital nonbullous ichthyosiform erythroderma (HP:0007479) | 1.96635532 |
| 87 | Urticaria (HP:0001025) | 1.96283108 |
| 88 | T lymphocytopenia (HP:0005403) | 1.96141263 |
| 89 | Camptodactyly of toe (HP:0001836) | 1.95842968 |
| 90 | J-shaped sella turcica (HP:0002680) | 1.95018275 |
| 91 | Agnosia (HP:0010524) | 1.94106530 |
| 92 | Retinal atrophy (HP:0001105) | 1.93738176 |
| 93 | Follicular hyperkeratosis (HP:0007502) | 1.93199318 |
| 94 | Arnold-Chiari malformation (HP:0002308) | 1.93165370 |
| 95 | Conjunctival telangiectasia (HP:0000524) | 1.92560107 |
| 96 | Arterial thrombosis (HP:0004420) | 1.92381801 |
| 97 | Abnormal platelet volume (HP:0011876) | 1.92118741 |
| 98 | Vertigo (HP:0002321) | 1.90975093 |
| 99 | Loss of speech (HP:0002371) | 1.90520754 |
| 100 | Cellulitis (HP:0100658) | 1.90023056 |
| 101 | Inappropriate behavior (HP:0000719) | 1.90018372 |
| 102 | Osteomyelitis (HP:0002754) | 1.89761982 |
| 103 | Hepatosplenomegaly (HP:0001433) | 1.88079903 |
| 104 | Stomatitis (HP:0010280) | 1.86833705 |
| 105 | Neuronal loss in central nervous system (HP:0002529) | 1.84849317 |
| 106 | Metaphyseal cupping (HP:0003021) | 1.84361077 |
| 107 | Aplasia/Hypoplasia involving the sinuses (HP:0009120) | 1.84294288 |
| 108 | Cervical subluxation (HP:0003308) | 1.82768639 |
| 109 | Abnormality of T cell number (HP:0011839) | 1.81729163 |
| 110 | Chest pain (HP:0100749) | 1.80953632 |
| 111 | Hyperextensible skin (HP:0000974) | 1.80826839 |
| 112 | Cerebral inclusion bodies (HP:0100314) | 1.80551530 |
| 113 | Joint stiffness (HP:0001387) | 1.80077859 |
| 114 | Progressive visual loss (HP:0000529) | 1.79995299 |
| 115 | Primitive reflexes (palmomental, snout, glabellar) (HP:0002476) | 1.79376607 |
| 116 | Chronic obstructive pulmonary disease (HP:0006510) | 1.78278358 |
| 117 | Obstructive lung disease (HP:0006536) | 1.78278358 |
| 118 | Mitral stenosis (HP:0001718) | 1.77982705 |
| 119 | Leukocytosis (HP:0001974) | 1.77609803 |
| 120 | Meningitis (HP:0001287) | 1.77254300 |
| 121 | Increased mean platelet volume (HP:0011877) | 1.76414380 |
| 122 | Periodontitis (HP:0000704) | 1.76277455 |
| 123 | Broad ribs (HP:0000885) | 1.76211839 |
| 124 | Wormian bones (HP:0002645) | 1.75725099 |
| 125 | Urethral obstruction (HP:0000796) | 1.75651091 |
| 126 | Pulmonary embolism (HP:0002204) | 1.75488832 |
| 127 | Blue sclerae (HP:0000592) | 1.75354772 |
| 128 | Interstitial pulmonary disease (HP:0006530) | 1.75208886 |
| 129 | Clumsiness (HP:0002312) | 1.74424793 |
| 130 | Aplasia/Hypoplasia of the frontal sinuses (HP:0009119) | 1.72446547 |
| 131 | Elevated erythrocyte sedimentation rate (HP:0003565) | 1.71808714 |
| 132 | Metaphyseal dysplasia (HP:0100255) | 1.70986093 |
| 133 | Spontaneous hematomas (HP:0007420) | 1.70686872 |
| 134 | Global brain atrophy (HP:0002283) | 1.70604640 |
| 135 | Prostate neoplasm (HP:0100787) | 1.70188950 |
| 136 | Bladder diverticulum (HP:0000015) | 1.69370311 |
| 137 | Pathologic fracture (HP:0002756) | 1.68484071 |
| 138 | Craniofacial hyperostosis (HP:0004493) | 1.68337385 |
| 139 | Thin bony cortex (HP:0002753) | 1.66645505 |
| 140 | Femoral bowing (HP:0002980) | 1.66071555 |
| 141 | Premature skin wrinkling (HP:0100678) | 1.65331956 |
| 142 | Round ear (HP:0100830) | 1.64720031 |
| 143 | Fragile skin (HP:0001030) | 1.64338451 |
| 144 | Coronal craniosynostosis (HP:0004440) | 1.60788830 |
| 145 | Onion bulb formation (HP:0003383) | 1.58011037 |
| 146 | Scapular winging (HP:0003691) | 1.57138045 |
| 147 | Supranuclear gaze palsy (HP:0000605) | 1.56604508 |
| 148 | Basal ganglia calcification (HP:0002135) | 1.56208851 |
| 149 | Obstructive sleep apnea (HP:0002870) | 1.55907162 |
| 150 | Corneal dystrophy (HP:0001131) | 1.55875474 |
| 151 | Abnormality of the peritoneum (HP:0002585) | 1.54796158 |
| 152 | Mitral regurgitation (HP:0001653) | 1.54397072 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | TGFBR2 | 5.24354768 |
| 2 | RIPK4 | 3.79586371 |
| 3 | BLK | 2.71212200 |
| 4 | GRK7 | 2.57685547 |
| 5 | EPHB1 | 2.46125407 |
| 6 | STK39 | 2.38543459 |
| 7 | MAPK15 | 2.29925650 |
| 8 | CAMK1D | 1.82584843 |
| 9 | OXSR1 | 1.75912562 |
| 10 | TAOK3 | 1.73633414 |
| 11 | EPHB2 | 1.73582767 |
| 12 | CSF1R | 1.68235166 |
| 13 | MAPKAPK5 | 1.66161954 |
| 14 | PBK | 1.60512689 |
| 15 | STK10 | 1.56687867 |
| 16 | CLK1 | 1.55881593 |
| 17 | MAP2K3 | 1.55850083 |
| 18 | MAP3K14 | 1.52406768 |
| 19 | DMPK | 1.50540683 |
| 20 | SYK | 1.49064708 |
| 21 | CAMK1G | 1.47995032 |
| 22 | TYK2 | 1.46496838 |
| 23 | SGK2 | 1.43771195 |
| 24 | IRAK4 | 1.40979583 |
| 25 | MST1R | 1.40843453 |
| 26 | TRPM7 | 1.38284141 |
| 27 | ACVR1B | 1.38222292 |
| 28 | IRAK3 | 1.36878410 |
| 29 | WNK1 | 1.36602278 |
| 30 | KIT | 1.34401825 |
| 31 | TBK1 | 1.28526226 |
| 32 | PIM2 | 1.27767381 |
| 33 | JAK1 | 1.27564993 |
| 34 | FGR | 1.26731914 |
| 35 | BTK | 1.26308167 |
| 36 | TEC | 1.26143561 |
| 37 | NEK9 | 1.23657322 |
| 38 | IKBKB | 1.22844268 |
| 39 | DDR2 | 1.22087094 |
| 40 | HCK | 1.16498169 |
| 41 | PKN1 | 1.13398543 |
| 42 | MAP3K6 | 1.11724859 |
| 43 | TNK2 | 1.10204567 |
| 44 | MAP3K13 | 1.09325813 |
| 45 | SGK3 | 1.08354063 |
| 46 | MET | 1.08308174 |
| 47 | CSK | 1.07800637 |
| 48 | MARK3 | 1.07017529 |
| 49 | WNK4 | 1.06810110 |
| 50 | EPHA3 | 1.06201208 |
| 51 | CDC42BPA | 1.05297820 |
| 52 | NLK | 1.02613915 |
| 53 | MAP3K2 | 1.01256355 |
| 54 | MAP3K3 | 1.01114245 |
| 55 | MAP3K1 | 0.96751275 |
| 56 | MARK2 | 0.93103195 |
| 57 | TXK | 0.89316046 |
| 58 | ERN1 | 0.89273134 |
| 59 | MOS | 0.88887420 |
| 60 | BMPR2 | 0.88376993 |
| 61 | YES1 | 0.86946292 |
| 62 | FRK | 0.86423130 |
| 63 | ADRBK2 | 0.86290649 |
| 64 | BMX | 0.85564475 |
| 65 | MATK | 0.85278890 |
| 66 | PDGFRB | 0.82716858 |
| 67 | PRKD1 | 0.82360938 |
| 68 | CDK6 | 0.82359903 |
| 69 | FGFR2 | 0.81809125 |
| 70 | MAP4K1 | 0.81718608 |
| 71 | MST4 | 0.80911991 |
| 72 | NEK6 | 0.80761974 |
| 73 | NTRK1 | 0.79796279 |
| 74 | IRAK1 | 0.79032308 |
| 75 | PDK1 | 0.78553473 |
| 76 | SGK494 | 0.76292966 |
| 77 | SGK223 | 0.76292966 |
| 78 | LCK | 0.75958616 |
| 79 | PRKCH | 0.75049072 |
| 80 | TTN | 0.71353382 |
| 81 | RET | 0.71081172 |
| 82 | ITK | 0.70570684 |
| 83 | JAK2 | 0.67198346 |
| 84 | PIK3CA | 0.66544415 |
| 85 | TNIK | 0.65856369 |
| 86 | IRAK2 | 0.65666862 |
| 87 | STK24 | 0.64421718 |
| 88 | ERBB2 | 0.64344485 |
| 89 | PAK2 | 0.64305795 |
| 90 | GSK3A | 0.64081888 |
| 91 | RPS6KA2 | 0.63507423 |
| 92 | LYN | 0.63266957 |
| 93 | PRKCE | 0.63220745 |
| 94 | CAMKK2 | 0.63100768 |
| 95 | DAPK2 | 0.62661207 |
| 96 | ABL1 | 0.61944831 |
| 97 | MAP3K5 | 0.61938153 |
| 98 | PAK4 | 0.61912679 |
| 99 | MAPK7 | 0.60892031 |
| 100 | JAK3 | 0.60667759 |
| 101 | IGF1R | 0.60395245 |
| 102 | GRK6 | 0.60385598 |
| 103 | MAP3K11 | 0.60065267 |
| 104 | PRPF4B | 0.59793712 |
| 105 | LIMK1 | 0.59504803 |
| 106 | PDPK1 | 0.59381148 |
| 107 | ZAP70 | 0.59371611 |
| 108 | PDGFRA | 0.59312497 |
| 109 | FYN | 0.58816253 |
| 110 | GRK5 | 0.58566460 |
| 111 | ABL2 | 0.58480158 |
| 112 | MAPK12 | 0.58364867 |
| 113 | MAPKAPK2 | 0.57479617 |
| 114 | IKBKE | 0.56522512 |
| 115 | MAP2K4 | 0.56459589 |
| 116 | EIF2AK2 | 0.54274651 |
| 117 | FER | 0.53646996 |
| 118 | PRKAA2 | 0.53637511 |
| 119 | RIPK1 | 0.53634532 |
| 120 | ROCK2 | 0.53558654 |
| 121 | CAMK4 | 0.53174024 |
| 122 | INSR | 0.53155185 |
| 123 | MYLK | 0.52704955 |
| 124 | RPS6KL1 | 0.51367850 |
| 125 | RPS6KC1 | 0.51367850 |
| 126 | FGFR3 | 0.48691138 |
| 127 | EGFR | 0.48522267 |
| 128 | MAP3K7 | 0.48441628 |
| 129 | PIK3CG | 0.47667360 |
| 130 | TAOK1 | 0.46257507 |
| 131 | STK11 | 0.46217423 |
| 132 | PINK1 | 0.45848726 |
| 133 | RPS6KA6 | 0.45671437 |
| 134 | MAPK4 | 0.45418991 |
| 135 | AKT3 | 0.44864029 |
| 136 | SRC | 0.44190921 |
| 137 | PTK2B | 0.43337423 |
| 138 | CDK3 | 0.43034223 |
| 139 | TIE1 | 0.42953658 |
| 140 | PAK3 | 0.42859227 |
| 141 | FES | 0.42172087 |
| 142 | DAPK3 | 0.40800037 |
| 143 | BCR | 0.39918219 |
| 144 | ERBB3 | 0.39692784 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 2.93994612 |
| 2 | Other glycan degradation_Homo sapiens_hsa00511 | 2.29516017 |
| 3 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 2.16263588 |
| 4 | Pertussis_Homo sapiens_hsa05133 | 2.14501399 |
| 5 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 2.09115094 |
| 6 | Malaria_Homo sapiens_hsa05144 | 2.08573688 |
| 7 | Leishmaniasis_Homo sapiens_hsa05140 | 2.08049928 |
| 8 | Lysosome_Homo sapiens_hsa04142 | 2.05165971 |
| 9 | Osteoclast differentiation_Homo sapiens_hsa04380 | 1.88273581 |
| 10 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 1.70377805 |
| 11 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 1.56284822 |
| 12 | Phagosome_Homo sapiens_hsa04145 | 1.56116164 |
| 13 | Tuberculosis_Homo sapiens_hsa05152 | 1.54063730 |
| 14 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 1.52588341 |
| 15 | ECM-receptor interaction_Homo sapiens_hsa04512 | 1.52385156 |
| 16 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 1.45853617 |
| 17 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 1.42405903 |
| 18 | Salmonella infection_Homo sapiens_hsa05132 | 1.40417177 |
| 19 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 1.37680979 |
| 20 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 1.31944495 |
| 21 | Graft-versus-host disease_Homo sapiens_hsa05332 | 1.29747407 |
| 22 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 1.28036320 |
| 23 | Amoebiasis_Homo sapiens_hsa05146 | 1.27331622 |
| 24 | Prion diseases_Homo sapiens_hsa05020 | 1.23821833 |
| 25 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 1.22525554 |
| 26 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 1.22423151 |
| 27 | Toxoplasmosis_Homo sapiens_hsa05145 | 1.19442313 |
| 28 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 1.17525785 |
| 29 | Platelet activation_Homo sapiens_hsa04611 | 1.14337221 |
| 30 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 1.13614578 |
| 31 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 1.12854503 |
| 32 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 1.11493363 |
| 33 | Focal adhesion_Homo sapiens_hsa04510 | 1.08463489 |
| 34 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 1.08236602 |
| 35 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 1.07212711 |
| 36 | Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 1.06003828 |
| 37 | Ether lipid metabolism_Homo sapiens_hsa00565 | 1.04264618 |
| 38 | Antigen processing and presentation_Homo sapiens_hsa04612 | 1.04088669 |
| 39 | Legionellosis_Homo sapiens_hsa05134 | 1.01481891 |
| 40 | Allograft rejection_Homo sapiens_hsa05330 | 1.00567502 |
| 41 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.99799494 |
| 42 | TNF signaling pathway_Homo sapiens_hsa04668 | 0.99747325 |
| 43 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.98950389 |
| 44 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 0.98337012 |
| 45 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.97755951 |
| 46 | Axon guidance_Homo sapiens_hsa04360 | 0.97235795 |
| 47 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.96266768 |
| 48 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 0.94890259 |
| 49 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 0.94700003 |
| 50 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 0.93347132 |
| 51 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.91662869 |
| 52 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 0.89946710 |
| 53 | Endocytosis_Homo sapiens_hsa04144 | 0.89202353 |
| 54 | Proteoglycans in cancer_Homo sapiens_hsa05205 | 0.87820532 |
| 55 | Shigellosis_Homo sapiens_hsa05131 | 0.86356476 |
| 56 | Rap1 signaling pathway_Homo sapiens_hsa04015 | 0.84153689 |
| 57 | Measles_Homo sapiens_hsa05162 | 0.82339183 |
| 58 | Adherens junction_Homo sapiens_hsa04520 | 0.81831401 |
| 59 | Pancreatic cancer_Homo sapiens_hsa05212 | 0.81455923 |
| 60 | Asthma_Homo sapiens_hsa05310 | 0.77116779 |
| 61 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 0.75732214 |
| 62 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 0.74219889 |
| 63 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.73706245 |
| 64 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 0.73295151 |
| 65 | Renin secretion_Homo sapiens_hsa04924 | 0.72952556 |
| 66 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 0.72188449 |
| 67 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.70850809 |
| 68 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 0.70697540 |
| 69 | Influenza A_Homo sapiens_hsa05164 | 0.70426939 |
| 70 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 0.70332607 |
| 71 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 0.69812359 |
| 72 | TGF-beta signaling pathway_Homo sapiens_hsa04350 | 0.69322259 |
| 73 | Ras signaling pathway_Homo sapiens_hsa04014 | 0.69200131 |
| 74 | Protein digestion and absorption_Homo sapiens_hsa04974 | 0.68833207 |
| 75 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.68005399 |
| 76 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.67320796 |
| 77 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.66765558 |
| 78 | Viral myocarditis_Homo sapiens_hsa05416 | 0.65619358 |
| 79 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 0.64561673 |
| 80 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.64162924 |
| 81 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 0.62942314 |
| 82 | Dilated cardiomyopathy_Homo sapiens_hsa05414 | 0.62573814 |
| 83 | Hypertrophic cardiomyopathy (HCM)_Homo sapiens_hsa05410 | 0.61701913 |
| 84 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 0.60766773 |
| 85 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.60744797 |
| 86 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 0.60143971 |
| 87 | Steroid biosynthesis_Homo sapiens_hsa00100 | 0.59870653 |
| 88 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.59769626 |
| 89 | PI3K-Akt signaling pathway_Homo sapiens_hsa04151 | 0.58828523 |
| 90 | Arrhythmogenic right ventricular cardiomyopathy (ARVC)_Homo sapiens_hsa05412 | 0.58127071 |
| 91 | Nitrogen metabolism_Homo sapiens_hsa00910 | 0.57087638 |
| 92 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 0.56150643 |
| 93 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.56032842 |
| 94 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 0.56030797 |
| 95 | Hepatitis B_Homo sapiens_hsa05161 | 0.55799432 |
| 96 | Serotonergic synapse_Homo sapiens_hsa04726 | 0.55634357 |
| 97 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.55091503 |
| 98 | Notch signaling pathway_Homo sapiens_hsa04330 | 0.55062748 |
| 99 | Apoptosis_Homo sapiens_hsa04210 | 0.54716351 |
| 100 | Gastric acid secretion_Homo sapiens_hsa04971 | 0.53868277 |
| 101 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 0.53687937 |
| 102 | Estrogen signaling pathway_Homo sapiens_hsa04915 | 0.53677662 |
| 103 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 0.52731186 |
| 104 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 0.52143174 |
| 105 | Glioma_Homo sapiens_hsa05214 | 0.51493199 |
| 106 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.50336629 |
| 107 | ErbB signaling pathway_Homo sapiens_hsa04012 | 0.50302896 |
| 108 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 0.49978819 |
| 109 | Mineral absorption_Homo sapiens_hsa04978 | 0.49846582 |
| 110 | Melanoma_Homo sapiens_hsa05218 | 0.49259938 |
| 111 | Hepatitis C_Homo sapiens_hsa05160 | 0.48738008 |
| 112 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.48626462 |
| 113 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 0.48317192 |
| 114 | Gap junction_Homo sapiens_hsa04540 | 0.48206681 |
| 115 | Pathways in cancer_Homo sapiens_hsa05200 | 0.47922969 |
| 116 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 0.47866295 |
| 117 | Long-term depression_Homo sapiens_hsa04730 | 0.47272139 |
| 118 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.46957525 |
| 119 | Oxytocin signaling pathway_Homo sapiens_hsa04921 | 0.46188940 |
| 120 | Salivary secretion_Homo sapiens_hsa04970 | 0.44761518 |
| 121 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.44553186 |
| 122 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 0.44251517 |
| 123 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.43825081 |
| 124 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.43566358 |
| 125 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.43429606 |
| 126 | cGMP-PKG signaling pathway_Homo sapiens_hsa04022 | 0.41374372 |

